COMPOSITIONS AND METHODS FOR IN VITRO DIAGNOSTIC TESTS INCLUDING SULFONIC ACID

(19)

(11)

EP 2 841 592 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	03.05.2017 Bulletin 2017/18

(45)	Mention of the grant of the patent:
	22.02.2017 Bulletin 2017/08

(21)	Application number: 13717896.8

(22)	Date of filing: 22.03.2013

(51)

International Patent Classification (IPC):

C12Q 1/28^(2006.01)
G01N 33/535^(2006.01)
G01N 33/58^(2006.01)

G01N 33/52^(2006.01)
G01N 33/558^(2006.01)

(86)	International application number:
	PCT/US2013/033429

(87)	International publication number:
	WO 2013/142758 (26.09.2013 Gazette 2013/39)

(54)	COMPOSITIONS AND METHODS FOR IN VITRO DIAGNOSTIC TESTS INCLUDING SULFONIC ACID ZUSAMMENSETZUNGEN UND VERFAHREN FÜR DIAGNOSTISCHE IN-VITRO-TESTS UNTER VERWENDUNG VON SULFONSÄURE COMPOSITIONS ET PROCÉDÉS POUR TESTS DE DIAGNOSTIC IN VITRO COMPORTANT DE L'ACIDE SULFONIQUE

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

23.03.2012 US 201261614602 P

(43)	Date of publication of application:
	04.03.2015 Bulletin 2015/10

(73)	Proprietor: Surmodics IVD, Inc.
	Eden Prairie, MN 55344 (US)

(72)	Inventors:
	OPPERMAN, Gary St. Louis Park, Minnesota 55426 (US) NELSON, Wendy Woodbury, Minnesota 55129 (US)

(74)	Representative: Schiweck, Weinzierl & Koch Patentanwälte Partnerschaft mbB
	Landsberger Straße 98 80339 München 80339 München (DE)

(56)

References cited: :

EP-A1- 2 405 016
US-A1- 2004 219 620

US-A- 4 778 757
US-A1- 2005 158 815

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).